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Objectives. We examined the prognostic significance of precor- 
dial ST segment depression among patients with an acute inferior 
myocardial infarction. 
Background. Although precordial ST segment depression has 
been associated with a poor prognosis, this correlation has not 
been adequately quantified, partly because of small sample sizes 
and methodologic l mitations in previous studies. 
Methods. We examined the clinical and angiographic outcomes 
of 16,521 patients with an acute inferior myocardial infarction 
who underwent thrombolysis in the Global Utilization of Strep- 
tokinase and t-PA for Occluded Coronary Arteries (GUSTO-I) 
study. Patients were classified into those without precordiai ST 
segment depression (n = 6,422 [38.9%]), those with ST segment 
depression in leads V~ to V 3 only (n = 5,850 [35.4%]), those with 
ST segment depression in leads V 4 to V 6 only (n = 876 [5.3%]) 
and those with ST segment depression i  both leads V x to V3 and 
leads V4 to V 6 (n = 3,373 [20.4%]) on initial electrocardiography. 
Outcome measures included postinfarction complications 
(second- or third-degree heart block, congestive heart failure or 
shock) and 30-day and 1-year mortality. 
Results. Patients with precordial ST segment depression had 
larger infarctions, more postinfarction complications and a 
higher mortality rate than those without precordial ST segment 
depression (4.7% vs. 3.2% at 30 days; 5.0% vs. 3.4% at 1 year; both 
p < 0.001), regardless of whether ST segment depression was 
noted in leads V 1 to V6 or in leads V4 to V6. The magnitude of 
precordial ST segment depression (sum of leads VI to V6) added 
significant independent prognostic information after adjustment 
for clinical risk factors; the risk of 30-day mortality increased by 
36% for every 0.5 mV of precordial ST segment depression. 
Conclusions. Assessment of the magnitude of precordial ST 
segment depression is useful for acute risk stratification in 
patients with an inferior myocardial infarction. 
(J Am Coil Cardioi 1996;28:305-12) 
In 1980, Shah et al. (1) first reported that precordial ST 
segment depression was a marker for increased risk in patients 
with an inferior myocardial infarction. Since then, its patho- 
genesis and prognostic importance have been heavily debated 
(2-39). Three potential etiologies for precordial ST segment 
depression have been proposed: 1) that it represents purely 
"reciprocal changes" resulting from inferior ST segment ele- 
vation; 2) that it results from anterior myocardial ischemia 
during an inferior infarction, and thus is a marker for multives- 
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sel coronary artery disease; or 3) that it results from a more 
extensive inferior infarction involving the posterolateral wall or 
the right ventricle, or both. 
The prognostic importance of precordial ST segment de- 
pression also remains unclear. Although many studies have 
reported that patients with precordial ST segment depression 
appear to have larger infarctions, few studies have found any 
significant difference in short- or long-term survival between 
those with and without this marker (40). There are several 
potential explanations for this contradiction: 1)Many of these 
previous eries had a limited number of patients--33 of 36 
studies included <100 patients--thus increasing the potential 
to miss a significant outcome difference. 2) Most studies 
classified patients into those with or without ST segment 
depression without considering the magnitude of the ST 
segment depression. 3)The pattern and lead distribution of ST 
segment depression may influence its prognostic significance. 
For example, Hsadia et al. (36) have reported that patients 
with ST segment depression i leads V4 to V 6 have a poorer 
prognosis than those whose ST segment depression is limited 
to leads V 1 to V 3 (36). 
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The purpose of our study was to qualitatively analyze the 
pathogenesis and prognostic significance of precordial ST 
segment depression in a large population of patients with 
inferior myocardial infarction treated in the thrombolytic era. 
Through the Global Utilization of Streptokinase and t-PA 
(tissue-type plasminogen activator) for Occluded Coronary 
Arteries (GUSTO-I) clinical data base (41), we had access to 
detailed clinical, electrocardiographic (ECG) and angio- 
graphic information for > 16,000 patients with an acute inferior 
infarction. 
Methods  
Patient population. The study population was drawn from 
patients who had an inferior myocardial infarction and who 
were enrolled in the GUSTO-I study. Patients were eligible for 
GUSTO-I if they presented within 6 h of the onset of chest 
pain and were found to have >-0.1-mV ST segment elevation in 
two or more limb leads or >-0.2 mV-elevation i  two or more 
precordial leads on their initial ECG. Exclusion criteria were 
limited to known contraindications to thrombolytic therapy. A
complete description of the organization and conduct of the 
GUSTO-I study has been reported elsewhere (41). 
Treatment strategies. Patients were randomized to one of 
four thrombolytic/heparin regimens: streptokinase with either 
subcutaneous or intravenous heparin, accelerated recombinant 
tissue-type plasminogcn activator (rt-PA) with intravenous 
heparin or both streptokinase and rt-PA with intravenous 
heparin. Additional treatment--chewable aspirin (>-160 rag/day) 
and beta-adrenergic blockade (intravenous atenolol, two 5-rag 
doses, followed by 50 to 100 mg orally per day)--was admin- 
istered to patients who had no contraindications. All other 
pharmacologic and interventional treatments were adminis- 
tered at the discretion of the attending physician. 
Electrocardiographic riteria. Enrollment ECGs were in- 
terpreted by a central Core Laboratory (Duke University, 
Durham, North Carolina) without knowledge of patient out- 
comes. For the current study, an inferior myocardial infarction 
was defined as ->0.1-mV ST segment elevation in at least two 
of the three inferiorly oriented leads: II, III and aVF. Patients 
who had left or right bundle branch block, ventricular paced 
rhythm, evidence of a prior infarction (significant O waves in 
leads that had no ST segment elevation) or uninterpretable 
ECG results were excluded from this analysis because these 
conditions may interfere with the classification of ST segment 
deviations. Finally, a small percentage of patients had both 
anterior (leads V 1 to V3) and inferior ST segment elevation. 
Those patients in whom the sum (Z) of anterior ST segment 
elevation (~ leads V 1 to V3) exceeded the sum of 
inferior ST segment elevation (]~ leads II, III and aVF) 
were considered to have had an anterior infarction and 
were excluded from the analysis. 
The degree of ST segment deviation was determined for all 
leads (measured at 60 ms after the J point relative to the TP 
segment). Patients who had ->0.1-mV ST segment depression 
in at least two precordial eads were considered to have 
precordial ST segment depression. For the primary analyses, 
patients were classified into one of four categories based on the 
distribution of precordial ST segment depression--group 1 = 
those with no significant precordial ST segment depression; 
group 2 = those with ST segment depression i leads V1 to V3 
only; group 3 = those with ST segment depression i leads V4 
to V6 only; and group 4 = those with widespread ST segment 
depression i both leads V 1 to V 3 and leads V 4 to V 6. This lead 
distribution classification pattern was chosen to be consistent 
with previous studies. Other patterns of ECG classification 
(e.g., defining group 2 as those with ST segment depression i
leads V1 to V 4 and group 3 as those with ST segment 
depression i  leads V5 to V~ and leads I and aVL) were also 
examined; however, they were less capable of discriminating 
patient outcomes than our primary classification scheme. 
Data collection. Baseline clinical and demographic data 
were collected for all patients enrolled in the GUSTO-I 
study. In-hospital clinical events were also reported pro- 
spectively by the site investigators according to standardized 
definitions and included congestive heart failure, cardio- 
genic shock, second- or third-degree heart block, sustained 
ventricular tachycardia or fibrillation requiring cardiover- 
sion, reinfarction and stroke. Angiographic data were avail- 
able for 57.5% of patients who underwent diagnostic ardiac 
catheterization before hospital discharge. Angiograms were 
analyzed for infarct location, degree of stenosis, number of 
diseased vessels, Thrombolysis in Myocardial Infarction 
(TIMI) flow grade (42) in the infarct-related artery and left 
ventricular ejection fraction. One-year survival data were 
available for 99% of the patients. 
Statistical analysis. Continuous data are summarized as 
medians with 25th and 75th percentiles, and categorical vari- 
ables as percentages, unless otherwise indicated. Selected 
baseline characteristics and clinical outcomes were compared 
among the four groups by chi-square tests for discrete variables 
and by nonparametric analysis of variance (Kruskal-Wallis) for 
continuous variables. The Spearman correlation coefficient 
was used to summarize the relation between measurement of 
inferior ST segment elevation (~ leads II, III and aVF) and 
precordial ST segment depression. One-year survival 
was displayed for each ST segment depression classifi- 
cation with Kaplan-Meier survival curves. 
Logistic regression modeling was used to test whether the 
distribution and magnitude of ST segment elevation or depres- 
sion were predictive of 30-day mortality. Logistic regression 
models were also used to examine whether these predictors 
added independent prognostic information after adjustment 
for other baseline clinical risk factors. The clinical risk factors 
examined in these models were those previously identified by 
Lee et al. (43): age, systolic blood pressure, admission Killip 
class, heart rate, prior infarction, height, weight, time to 
thrombolytic treatment, ype of thrombolytic agent, diabetes, 
hypertension, current smoking, prior bypass surgery and 
known cerebrovascular disease (43). 
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Table 1. Baseline Clinical Characteristics by Precordial ST Segment Depression Classification 
ST Segment Depression 
No ST Segment 
Depression Leads Vj-V 3 Leads V4-V 6 Leads V1-V, + V4-V~, 
Characteristic (n = 6,422) (n - 5,850) (n = 876) (n = 3,373) 
Age (yr) 60 (50, 68) 61 (52, 69) 61 (53, 69) 61 (52, 69)* 
Systolic BP (ram Hg) 128 (110, 142) 128 (111, 142) 128 (110, 144) 127 (111,142) 
Heart rate (beats/rain) 70 (60, 80) 72 (61, 84)* 71 (60, 82) 72 (62, 85)* 
Male gender 73.0% 73.8% 78.3%* 79.5%* 
Hypertension 39.9% 35.7%* 34.9%* 34.0%* 
Diabetes mellitus 16.5% 11.6%* 13.1%* 9.2%* 
Current smoking 43.2% 46.9%* 50.3%* 54.0%* 
Hyperlipidemia 37.7% 37.3% 32.1%* 32.4%* 
Previous angina 33.4% 33.9% 38.5% 34.8% 
*p < 0.001 versus patients with no ST segment depression. Data are expressed as median values (25th, 75th 
percentiles) or percent of patients. BP = blood pressure. 
Results 
Study group. Baseline ECGs were available for analysis in 
38,006 (92.7%) of the 41,021 GUSTO-I patients. Of these, 
18,773 (49.4%) met our definition for an acute inferior infarc- 
tion. From this cohort, we excluded 567 patients (3.0%) with 
left bundle branch block, 444 (2.4%) with a paced rhythm or 
uninterpretable ECG and 1,241 (6.6%) with a prior Q wave 
infarction, leaving 16,521 patients in our final inferior infarc- 
tion cohort. 
Precordial ST segment depression was present in 10,099 of 
the patients (61.1%) with inferior infarction. Patients were 
classified into four exclusive groups on the basis of the 
presence and distribution of precordial ST segment depres- 
sion: group 1 -- patients without precordial ST segment 
depression (n = 6,422 [38.9%]), group 2 = those with ST 
segment depression i  leads Vi to V 3 only (n = 5,850 [35.4%]), 
group 3 = those with ST segment depression i leads V 4 to 
V 6 only (n = 876 [5.3%]) and group 4 = those with 
widespread ST segment depression i  both leads V 1 to V 3 
and leads V4 to V6 (n = 3,373 [20.4%]). Baseline clinical 
characteristics for each group are displayed in Table 1. 
Patients without precordial ST segment depression (group 
1) were less likely to be smokers and more likely to have 
hypertension or diabetes than patients with precordial ST 
segment depression (groups 2 to 4). Cardiac atheterization 
results are displayed in Table 2. The overall rate of in- 
hospital cardiac atheterization was 57.5%, with no signifi- 
cant difference in frequency among the four groups. The 
median time from thrombolysis to diagnostic ardiac cath- 
eterization was 4 days for each subgroup. The proportion of 
patients with significant (->70%) stenosis in the left anterior 
descending coronary artery was similar for those with and 
without precordial ST segment depression (25% vs. 24%, 
p > 0.1). Similarly, the percentage ofpatients with multives- 
sel coronary artery disease did not vary by the presence or 
distribution of precordial ST segment depression. However, 
patients who had ST segment depression i  leads V 1 to V 3 
were more likely to have involvement of the left circumflex 
artery compared with patients in the other groups. Left 
ventricular ejection fraction was significantly lower in pa- 
tients who had ST segment depression in leads V1 to V3 
(group 2) or widespread ST segment depression (group 4) 
Table 2. Catheterization Results by Precordial ST Segment Depression Classification 
ST Segment Depression 
No ST Segment 
Depression Leads Vt-V 3 Leads V4-V~, Leads VI-V 3 z_ V4 Vh 
(n - 3,817) (n - 3,351) (11 = 497) (n - 1,851) 
Catheterization performed 59% 57% 57% 55% 
->70% stenosis 
LAD 25% 24% 26% 24% 
LCx 28% 40%* 28% 34%* 
RCA 74% 66%* 77% 75%* 
Multivessel disease 29% 30% 32% 32% 
TIMI grade 3 flow 46% 51% 53% 48% 
LVEF (%) 56 (50, 65) 54 (47, 61)* 56 (50, 64) 54 (45, 60)* 
*p < 0.001 versus patients with no ST segment depression. Data presented are medians (25th, 75th percentiles) or 
percent of patients. LAD = left anterior descending coronary artery; LCx = left circumflex coronary artery.; LVEF = left 
verltricular ejection fraction; RCA = right coronary artery; TIMI grade 3 flow = Thombolysis in Myocardial Infarction 
grade 3 flow (42) in the infarct-related artery 90 rain after start of thrombolysis for patients in the GUSTO-I angiographic 
substudy (n = 953) (45). 
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Table 3. Therapy Received by Precordial ST Segment Depression Classification 
ST Segment Depression 
No ST Segment 
Depression Leads VI-V 3 Leads V4-V6 Leads Wl-W 3 q- V4-V 6 
Post-MI Treatment (n = 6,422) (n = 5,850) (n = 876) (n = 3,373) 
Thrombolytic therapy 
Accelerated rt-PA 24.8 26.1 24.8 25.5 
SK-IV heparin 24.7 25.6 25.9 25.3 
Combination 25.6 25.0 25.2 26.2 
SK-SQ heparin 24.9 23.3 24.1 23.1 
Aspirin 97.5 97.7 96.8 97.9 
Nitrates 87.5 86.2 83.5* 84.6* 
Beta-blockers 76.8 75.8 73.0 72.9* 
Calcium channel blockers 33.9 30.6* 32.8 28.4* 
ACE inhibitors 11.6 13.3 13.9 13.4" 
Digitalis 8.7 10.2 8.8 11.5" 
Coronary angioplasty 28.2 27.9 27.5 28.7 
Bypass surgery 8.5 7.9 8.7 8.2 
*p < 0.001 versus patients with no ST segment depression. Data are expressed as percent of patients. ACE = 
angiotensin-converting en~me; Combination = recombinant issue-type plasminogen activator (rt-PA) and streptoki- 
nase (SK) with intravenous (IV) heparin; SC = subcutaneous. 
than in those who had no ST segment depression (group 1) 
or ST segment depression in leads V4 to V6 only (group 3). 
In-hospital treatment. All patients in this study received 
thrombolytic therapy according to the GUSTO-I protocol 
(Table 3). The use of aspirin and nitrates was similarly high 
(overall averages 98% and 86%, respectively) in all subgroups. 
Patients without precordial ST segment depression (group 1) 
were more likely than those with ST segment depression to 
receive beta-blockers and calcium channel blockers and were 
less likely to receive digitalis or an angiotensin-converting 
enzyme inhibitor, partly reflecting a greater preservation of left 
ventricular function in these patients. The in-hospital use of 
coronary angioplasty and bypass surgery were similar in the 
four subgroups. 
Outcomes. Acute clinical outcomes by precordial ST seg- 
ment depression classification are displayed in Table 4. In 
general, patients with inferior infarction treated with throm- 
bolytic therapy had an excellent prognosis. Stroke occurred in 
1.3% of the patients, reinfarction in 4.2% and congestive heart 
failure in 11.6%; the 30-day mortality rate was 4.4%. Despite 
this low overall event rate, precordial ST segment depression 
remained an important predictor of poor outcomes among 
patients who had inferior infarction. Inferior infarction pa- 
tients who had no precordial ST segment depression (group 1) 
had significantly less myocardial damage as assessed by peak 
serum creatine kinase (CK) and had fewer postinfarction 
complications, including second- and third-degree atrioventric- 
ular block, ventricular tachycardia or fibrillation, congestive 
heart failure and cardiogenic shock, than those who had 
precordial ST segment depression (groups 2 to 4). Patients 
who had no precordial ST segment depression also had 
significantly lower in-hospital (3.2% vs. 4.7%, p < 0.001) 
Table 4. Clinical Outcomes by Precordial ST Segment Depression Classification 
ST Segment Depression 
No ST Segment 
Depresssion Leads V1-V 3 Leads V4-V~ Leads Vl-V 3 -~- V4-W 6 
(n = 6,422) (n = 5,850) (n = 876) (n = 3,373) 
Peak CK (IU/liter) 1,042 1,708' 1,131" 1,506" 
(523, 1,884) (925, 2,811) (552, 1,933) (810, 2,597) 
Congestive heart failure 9.6% 12.6%* 10.1% 13.9%* 
Cardiogenic shock 4.1% 4.3% 4.1% 6.8%* 
2°-3 ° AV block 10.9% 11.3% 10.5% 14.6%* 
VT/VF 7.5% 9.4%* 9.8%* 11.6%* 
Stroke 1.1% 1.3% 1.7% 1.8% 
Reinfarction 4.1% 4.3% 3.8% 4.2% 
Mortality rate 
30 days 3.4% 4.3%* 4.9%* 6.3%* 
1 yr 4.6% 6.1%* 6.5%* 8.9%* 
*p < 0.05 versus patients with no Sq segment depression. Data are expressed as medians (25th, 75th percentiles) or 
percent of patients. AV = atrioventricular; CK = creatine kinase; VT/VF = ventricular tachycardia/ventricular 
fibrillation. 
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Figure 1. One-year survival in patients with inferior myocardial infarc- 
tion and no ST segment depression (dashed line), ST segment 
depression i  leads V1 to V3 (thin solid line), ST segment depression 
in leads V4 to V 6 (solid line with circles) or ST segment depression i  
both leads V 1 to V 3 and leads V4 to V 6 (thick solid line). 
30-day (3.4% vs. 5.0%, p < 0.001) and 1-year mortality (4.6% 
vs. 7.0%, p < 0.001) than patients who had precordial ST 
segments depression. 
Among patients who had precordial ST segment depres- 
sion, those with depression i leads V i to V 3 or both V 1 to V 3 
and V4 to V 6 (groups 2 and 4) had higher peak CK levels than 
those with ST segment depression limited to leads V4 to V6 
(group 3)--median 1,708 IU/liter and 1,506 lU/liter versus 
1,131 IU/liter, respectively (p < 0.001). Postinfarction left 
ventricular function was also slightly worse in groups 2 and 4 
than in group 3--median ejection fraction 54% versus 56%, 
p < 0.001. The difference in myocardial damage was also 
demonstrated clinically by the more frequent congestive heart 
failure and shock in groups 2 and 4 than in group 3. Patients 
who had widespread ST segment depression (group 4) had the 
highest 30-day mortality rate (6.3%) compared with those with 
ST segment depression limited to leads Vt to V 3 (4.3%) or 
Table 5. Clinical Outcomes by Sum of Precordial ST 
Segment Depression 
Sum of Precordial ST Segment Depression (mY) 
<0.2 0.2 to <0.5 0.5 to <0.8 ->0.8 
(n = 5,633) (n = 4,716) (n = 3,005) (n = 3,167) 
Median peak CK 987 1,402' 1,578' 1,934' 
(IU/liter) 
Congestive heart 9.1% 10.8%* 11.8%* 16.9%* 
failure 
Cardiogenic shock 3.9% 3.8% 4.7% 7.7%* 
2°-3 ° AV block 10.1% 11.0% 12.7%* 15.0% *
VT/VF 7.0% 7.6% 10.1%* 14.1%* 
Stroke 1.1% 1.3% 1.4% 1.8% 
Reinfarction 3.9% 4.3% 4.6% 4.0% 
Mortality rate 
30 days 3.2% 3.9% 4.2%* 7.5%* 
1 yr 4.8% 5.4% 6.4%* 10.0%* 
*p < 0.01 versus those with <0.2 inV. Data are expressed as medians (25th, 
75th percentiles). Abbreviations as in Table 4. 
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Figure 2. Relation between the magnitude ofprecordial ST segment 
depression and 30-day mortality. The probability curve is displayed 
with 95% confidence limits. 
leads V4 to V 6 (4.9%) and those with no ST segment depres- 
sion (3.2%). This trend toward a poorer prognosis for patients 
with widespread ST segment depression continued throughout 
1 year, as shown in Figure 1. 
ST-segment depression versus outcomes. Table 5 and Fig- 
ure 2 examine the relation between the magnitude of precor- 
dial ST segment depression and patient outcomes. The 30-day 
mortality rate rose nonlinearly with the increasing degree of 
precordial ST segment depression (Z leads Va to V6). The sum 
of precordial ST segment depression also correlated with the 
amount of myocardial damage (higher peak CK measurements 
and more congestive heart failure and cardiogenic shock). For 
example, 19% of patients with inferior infarction in our data 
set had cumulative precordial ST segment depression of ->0.8 
inV. These patients had significantly higher peak CK levels 
(1,934 vs. 987 IU/liter, p < 0.001) and more frequently 
developed congestive heart failure (16.9% vs. 9.1%, p < 0.001) 
and cardiogenic shock (7.7% vs. 3.0%, p < 0.001) than those 
with little or no precordial ST segment depression. The 
frequency of significant heart block and life-threatening ar- 
rhythmias also increased with the increasing degree of precor- 
dial ST segment depression. In contrast, the sum of precordial 
Table 6. Thirty-Day Mortality Predictive Models 
Univariate Chi-Square Adjusted for 
Chi-Square Clinical Variables* 
~, inferior ST elevation (leads 16.6 13.9 
II, III, aVF) 
No. of leads with precordial ST 46.2 24.8 
depression 
Y~ ST depression 
Leads V1-V 3 64.3 34.8 
Leads V4-V 6 67.7 30.9 
Leads V I-V 6 87.1 44.8 
Leads VI-V6+~ inferior ST 71.2 40.8 
elevation 
*Age, systolic blood pressure, admission Killip class, heart rate, previous 
infarction, height, weight, time to thrombolytic treatment, type of thrombolytic 
agent, diabetes, hypertension, current smoking, prior bypass urgery and history 
of cerebrovascular disease. ~] - sum of. 
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ST segment depression did not correlate with reinfarction or 
stroke rates (p > 0.1). 
Table 6 displays the relations of selected ECG variables and 
30-day mortality before and after adjustment for baseline 
clinical prognostic factors. The sum of inferior ST segment 
elevation (Y, leads II, III and aVF) was the least significant 
ECG prognostic measure tested (univariable and adjusted 
chi-squares of 16.6 and 13.9, respectively). The prognostic 
significance of precordial ST segment depression i leads V1 to 
V3 was similar to that in leads V4 to V6. The sum of precordial 
ST segment depression (~ leads V~ to V6) was the most 
significant ECG predictor of 30-day mortality tested 
(univariable and adjusted chi-squares of 87.1 and 44.8, 
respectively). In fact, in a multivariable ECG and clinical 
analysis, no other ECG predictor was significant after 
accounting for this factor. 
Discuss ion 
The prognostic significance of precordial ST segment de- 
pression in patients with an inferior myocardial infarction has 
been controversial, in part because of the limited size of 
previous tudies. On examining data from 16,521 such patients 
from the GUSTO-I trial, we confirmed that those who had 
precordial ST segment depression had significantly larger 
infarctions, more postinfarction complications and higher mor- 
tality than those without precordial ST segment depression. 
Furthermore, the degree of precordial ST segment depression 
was a more powerful ECG predictor of outcome than the 
amount of inferior ST segment elevation. Poorer 30-day and 
1-year prognoses were found in all patients who had precordial 
ST segment depression, whether the changes were in leads V1 
to V 3 or leads V 4 to V 6. The best independent ECG predictor 
of patient outcomes after inferior infarction was the cumula- 
tive sum of precordial ST segment depression (leads V~ to Vr,). 
Pathophysiology of precordial ST segment depression. 
Previous investigators have put forth a number of explanations 
for precordial ST segment depression during an inferior in- 
farction. Researchers have proposed that precordial ST seg- 
ment depression is purely an ECG consequence of ST segment 
elevation in the inferior limb leads, without physiologic impor- 
tance (4,9,13,16,31-33). In contrast, we found that the magni- 
tude of inferior ST segment deviation correlated only margin- 
ally with precordial ST segment depression i  leads V1 to V 3 
(r = -0.44) and was not correlated with ST segment depres- 
sion in leads V4 to V6 (r : -0.09). We also demonstrated that 
precordial ST segment depression had considerable prognostic 
importance, xceeding that gained from examining the degree 
of inferior ST segment elevations. 
Others have proposed that precordial ST segment depres- 
sion during an inferior infarction signifies anterior wall isch- 
emia and thus is a marker for left anterior descending coronary 
artery or multivessel disease (3,10,19,20,23,27). In contrast, we 
found that the frequency of left anterior descending coronary 
artery disease did not vary by the presence or distribution of 
precordial ST segment depression, nor did the frequency of 
multivessel coronary artery disease. 
Still others have hypothesized that precordial ST segment 
depression iscaused by posterolateral wall involvement during 
an inferior infarction (1,2,6,11,29,30,35). Indeed, we found that 
patients who had ST segment depression i leads V 1 to V3 had 
larger infarctions, as shown by higher peak CK levels, more 
congestive heart failure symptoms and worse left ventricular 
ejection fractions. Likewise, we found that the circumflex 
artery, which often supplies blood to the posterior and lateral 
myocardium, was more often the infarct-related artery among 
patients with precordial ST segment depression i leads V1 to 
V 3. Thus, we conclude that precordial ST segment depression 
in leads V 1 to V 3 is a marker for larger inferior wall infarctions 
usually with extension to the posterolateral wall. 
This explanation, however, does not appear to explain ST 
segment depression i  leads V4 to V 6. Despite having lower 
peak CK levels and less severe left ventricular dysfunction than 
patients with ST segment depression i leads V~ to V3, patients 
with ST segment depression in leads V4 to V6 had similar 
30-day and 1-year mortality. This apparently paradoxical result 
(smaller infarctions yet poorer prognoses for inferior infarc- 
tion patients with ST segment depression i the lateral precor- 
dium) is consistent with the findings of others and deserves 
further investigation (36). 
Prognostic significance of precordial ST segment depres- 
sion. Patients who have an inferior infarction generally have a 
more favorable prognosis than those who have anterior infarc- 
tion. In the GUSTO-I trial, the unadjusted 30-day mortality 
rate for inferior infarction patients was 5.0% compared with 
9.9% for those who had an anterior infarction (43). It is clear, 
however, that patients with inferior infarction are a heteroge- 
neous group (34,40). From this large clinical series, we show 
that the magnitude of precordial ST segment depression is 
useful for the stratification of patients with inferior infarction 
into low and high risk categories. 
Few studies have been able to show that precordial ST 
segment depression can predict patient outcomes (21). Our 
study found that patients without precordial ST segment 
depression treated with acute thrombolytic therapy were at low 
risk with a 30-day mortality rate of 3.4%. In contrast, patients 
with >-0.8 mV of ST segment depression, despite receiving 
aggressive therapy, had a mortality rate of 7.5%, approaching 
that seen in patients with anterior infarction. We also found 
that a patient's risk for mortality increased in a near linear 
fashion with increasing precordial ST segment depression, 
whether the ST segment depression was in the anterior (VI to 
V3) or lateral precordial (V4 to V6) leads. Finally, the sum of 
precordial ST segment depression was a strong independent 
prognostic factor even after adjustment for the magnitude of 
inferior ST segment elevation and known clinical risk factors 
(see previous discussion). Even after considering baseline 
clinical risk factors, a patient's risk of 30-day mortality in- 
creased by 36% with every 0.5-mV increment of cumulative 
precordial ST segment depression (~ leads Vl to V6). 
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Study limitations. Although the present study is the largest 
report on outcomes after inferior myocardial infarction, cer- 
tain limitations need to be acknowledged. First, our study 
patients included those eligible for thrombolytic therapy who 
were selected for enrollment in a randomized clinical trial. In 
general, these patients tend to be somewhat healthier and have 
better outcomes than community-based populations (44). 
Thus, these results should ideally be confirmed in a large, 
unselected population with infarction. Second, our angio- 
graphic data were also selective, representing only patients 
who underwent catheterization at the discretion of the physi- 
cian. However, nearly 60% of our patients with inferior 
infarction underwent catheterization without significant varia- 
tion among our ECG classifications. Furthermore, these cath- 
eterization findings were similar when we limited our analysis 
to those who underwent catheterization as part of the 
GUSTO-I angiographic substudy (n = 953) (45). 
Finally, other investigators have reported that the prognos- 
tic significance of precordial ST segment depression may 
change over time, with persistent ECG changes being more 
predictive (28). We analyzed the tracings available to the 
clinician when acute treatment decisions were being made. 
Although we may have underestimated the predictive power of 
precordial ST segment depression by analyzing ECG changes 
at presentation, we believe that the results reflect its prognostic 
use in the emergency room setting. 
Clinical implications. In conclusion, when assessing risk in 
patients with acute inferior myocardial infarction, the clinician 
should consider the cumulative sum of ST segment depression 
in all precordial leads. Those without precordial ST segment 
depression are generally at low risk for postinfarction compli- 
cations or death; however, the risk for adverse outcomes 
increases significantly as the magnitude of precordial ST 
segment depression i creases (increasing 30-day mortality by a 
third with every 0.5 mV of ST segment depression). 
Because the benefits from many interventions are directly 
related to a patient's underlying risk for adverse outcomes, 
clinicians should consider a more aggressive diagnostic and 
therapeutic approach for inferior infarction patients with sig- 
nificant precordial ST segment depression, and a more conser- 
vative approach for those without precordial ST segment 
depression. Thus, the clinician can use this easily obtainable 
prognostic information from the initial ECG to help tailor 
therapeutic decisions in the management of patients with 
inferior myocardial infarction (46). 
We appreciate the editorial assistance of Pat Williams. 
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